Eye injections tested to save sight in rare coats disease
NCT ID NCT03940690
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether anti-VEGF injections into the eye could help treat Coats disease, a rare condition that causes abnormal blood vessels and fluid buildup in the retina, potentially leading to blindness. The trial included 18 people with early-stage Coats disease who had not received prior eye treatment. Researchers compared the effects of these injections combined with standard laser therapy to see if they could improve disease stage and reduce the need for repeat laser treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COATS' DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Bordeaux
Bourdeaux, 33076, France
-
CHU de Reims
Reims, France, 51092, France
-
Centre hospitalier René Dubos (Pontoise)
Cergy-Pontoise, France, 95303, France
-
Clinique Rive Gauche
Toulouse, France, 31000, France
-
Fondation Ophtalmologique A. de Rothschild
Paris, France, 75019, France
-
Hôpital Universitaire Necker Enfants Malades, APHP
Paris, France, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.